These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38666508)

  • 1. STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis.
    Ye Z; Lu X; Zhu M; Bi L; Yang F; Zhou B; Xu D; Yao L
    Mol Pharm; 2024 Jun; 21(6):2865-2877. PubMed ID: 38666508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy.
    Xu D; Lu X; Yang F; Jiang Z; Yang S; Bi L; Liu J; Shan H; Li D
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):641-655. PubMed ID: 37924341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury.
    Xu D; Yang F; Chen J; Zhu T; Wang F; Xiao Y; Liang Z; Bi L; Huang G; Jiang Z; Shan H; Li D
    Acta Pharm Sin B; 2023 May; 13(5):2124-2137. PubMed ID: 37250155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1-week extension of a ketogenic diet provides a further decrease in myocardial
    Clément A; Boutley H; Poussier S; Pierson J; Lhuillier M; Kolodziej A; Olivier JL; Karcher G; Marie PY; Maskali F
    J Nucl Cardiol; 2020 Apr; 27(2):612-618. PubMed ID: 30128917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate Receptor β-Targeted PET Imaging of Macrophages in Autoimmune Myocarditis.
    Jahandideh A; Uotila S; Ståhle M; Virta J; Li XG; Kytö V; Marjamäki P; Liljenbäck H; Taimen P; Oikonen V; Lehtonen J; Mäyränpää MI; Chen Q; Low PS; Knuuti J; Roivainen A; Saraste A
    J Nucl Med; 2020 Nov; 61(11):1643-1649. PubMed ID: 32284397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis.
    Maya Y; Werner RA; Schütz C; Wakabayashi H; Samnick S; Lapa C; Zechmeister C; Jahns R; Jahns V; Higuchi T
    J Nucl Med; 2016 Dec; 57(12):1985-1990. PubMed ID: 27390159
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Le TM; Lee HR; Abt ER; Rashid K; Creech AL; Liang K; Cui J; Cho A; Wei L; Labora A; Chan C; Sanchez E; Kriti K; Karin D; Li L; Wu N; Mona C; Carlucci G; Hugo W; Wu TT; Donahue TR; Czernin J; Radu CG
    J Nucl Med; 2023 Jan; 64(1):117-123. PubMed ID: 35738905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
    Werner RA; Wakabayashi H; Bauer J; Schütz C; Zechmeister C; Hayakawa N; Javadi MS; Lapa C; Jahns R; Ergün S; Jahns V; Higuchi T
    Eur Heart J Cardiovasc Imaging; 2019 Apr; 20(4):467-474. PubMed ID: 30102319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
    Ozawa K; Funabashi N; Daimon M; Takaoka H; Takano H; Uehara M; Kobayashi Y
    Int J Cardiol; 2013 Nov; 169(3):196-200. PubMed ID: 24075573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel
    Fang J; Feng L; Meng L; Wang X; Liu H; Huang L; Zhang D; Li J; Zhuang R; Guo Z; Zhang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):27-37. PubMed ID: 36066666
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Li X; Yang W; Ma W; Zhou X; Quan Z; Li G; Liu D; Zhang Q; Han D; Gao B; Li C; Wang J; Kang F
    J Nucl Cardiol; 2021 Oct; 28(5):2346-2357. PubMed ID: 32016690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
    Nensa F; Kloth J; Tezgah E; Poeppel TD; Heusch P; Goebel J; Nassenstein K; Schlosser T
    J Nucl Cardiol; 2018 Jun; 25(3):785-794. PubMed ID: 27638745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
    Chen W; Jeudy J
    Curr Cardiol Rep; 2019 Jun; 21(8):76. PubMed ID: 31243587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of
    Protonotarios A; Wicks E; Ashworth M; Stephenson E; Guttmann O; Savvatis K; Sekhri N; Mohiddin SA; Syrris P; Menezes L; Elliott P
    Int J Cardiol; 2019 Jun; 284():99-104. PubMed ID: 30409737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING-targeted PET imaging: unveiling tumor immunogenicity post-chemotherapy in colorectal cancer.
    Li C; Saladin RJ; Cai W; Chen W
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2758-2760. PubMed ID: 38771515
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography in clinically suspected myocarditis - STREAM study design.
    Ozierański K; Tymińska A; Kobylecka M; Caforio ALP; Šobić-Šaranović D; Ristić AD; Maksimović R; Seferović PM; Marcolongo R; Królicki L; Opolski G; Grabowski M
    Int J Cardiol; 2021 Jun; 332():113-118. PubMed ID: 33657398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
    Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
    Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection.
    Daly KP; Dearling JL; Seto T; Dunning P; Fahey F; Packard AB; Briscoe DM
    Transplantation; 2015 Sep; 99(9):e132-9. PubMed ID: 25675207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.